Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.00 Analyst target: $14.04 Upside: 1304.00%
XORTX Therapeutics Inc., a biopharmaceutical company, is dedicated to the development and commercialization of therapies to treat progressive kidney disease, hypertension, insulin resistance, and diabetic nephropathy. The company is headquartered in Vancouver, Canada.
See the full interactive analysis & chart →Informational only — not investment advice.